Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Itti

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
ESC Heart Failure|October 13, 2025
Nuclear imaging and echocardiographic findings in hypertrophic cardiomyopathy with and without ATTR-CMPablo Garcia-Pavia, Francisco Javier Haro Del Moral, Francesco Cappelli, et al.
Journal of the American College of Cardiology|November 26, 2021
Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering AnalysisLouis Bonnefous, Mounira Kharoubi, Mélanie Bézard, et al.
European Radiology|May 15, 2020
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CTSébastien Mulé, Julia Chalaye, François Legou, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2020
Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case-Control Comparison With Intravenous RituximabHugo Rotkopf, Michaël Lévy, Christiane Copie-Bergman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2023
Prognostic Value of <sup>18</sup>F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED StudyThomas Carlier, Gauthier Frécon, Diana Mateus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2014
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphomaMyriam Sasanelli, Michel Meignan, Corinne Haioun, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 3, 2016
Early-phase myocardial uptake intensity of <sup>99m</sup>Tc-HMDP vs <sup>99m</sup>Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosisMukedaisi Abulizi, Anne-Ségolène Cottereau, Aziz Guellich, et al.
Radiology|October 7, 2017
Whole-Body Diffusion-weighted MR Imaging of Iron Deposits in Hodgkin, Follicular, and Diffuse Large B-Cell LymphomaAnne-Ségolène Cottereau, Sébastien Mulé, Chieh Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2009
Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trialsMichel Meignan, Emmanuel Itti, Stéphane Bardet, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 27, 2025
Men and women differ with regard to the prevalence, phenotype, and prognosis of wild-type transthyretin amyloid cardiomyopathyAmira Zaroui, Charlotte Lafont, Mounira Kharoubi, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
ESC Heart Failure|October 13, 2025
Nuclear imaging and echocardiographic findings in hypertrophic cardiomyopathy with and without ATTR-CMPablo Garcia-Pavia, Francisco Javier Haro Del Moral, Francesco Cappelli, et al.
Journal of the American College of Cardiology|November 26, 2021
Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering AnalysisLouis Bonnefous, Mounira Kharoubi, Mélanie Bézard, et al.
European Radiology|May 15, 2020
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CTSébastien Mulé, Julia Chalaye, François Legou, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2020
Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case-Control Comparison With Intravenous RituximabHugo Rotkopf, Michaël Lévy, Christiane Copie-Bergman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2023
Prognostic Value of <sup>18</sup>F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED StudyThomas Carlier, Gauthier Frécon, Diana Mateus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2014
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphomaMyriam Sasanelli, Michel Meignan, Corinne Haioun, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 3, 2016
Early-phase myocardial uptake intensity of <sup>99m</sup>Tc-HMDP vs <sup>99m</sup>Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosisMukedaisi Abulizi, Anne-Ségolène Cottereau, Aziz Guellich, et al.
Radiology|October 7, 2017
Whole-Body Diffusion-weighted MR Imaging of Iron Deposits in Hodgkin, Follicular, and Diffuse Large B-Cell LymphomaAnne-Ségolène Cottereau, Sébastien Mulé, Chieh Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2009
Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trialsMichel Meignan, Emmanuel Itti, Stéphane Bardet, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 27, 2025
Men and women differ with regard to the prevalence, phenotype, and prognosis of wild-type transthyretin amyloid cardiomyopathyAmira Zaroui, Charlotte Lafont, Mounira Kharoubi, et al.
Pageof 15